HK1058009A1 - Pharmaceutical compositions for headache, migraine, nausea and emesis - Google Patents

Pharmaceutical compositions for headache, migraine, nausea and emesis

Info

Publication number
HK1058009A1
HK1058009A1 HK04100896.1A HK04100896A HK1058009A1 HK 1058009 A1 HK1058009 A1 HK 1058009A1 HK 04100896 A HK04100896 A HK 04100896A HK 1058009 A1 HK1058009 A1 HK 1058009A1
Authority
HK
Hong Kong
Prior art keywords
nausea
emesis
migraine
headache
pharmaceutical compositions
Prior art date
Application number
HK04100896.1A
Other languages
English (en)
Inventor
Raphael Barkan
Alexander Mirimsky
Original Assignee
Meditor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14463201A external-priority patent/IL144632A0/xx
Application filed by Meditor Pharmaceuticals Ltd filed Critical Meditor Pharmaceuticals Ltd
Publication of HK1058009A1 publication Critical patent/HK1058009A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
HK04100896.1A 2000-09-05 2004-02-11 Pharmaceutical compositions for headache, migraine, nausea and emesis HK1058009A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22981200P 2000-09-05 2000-09-05
IL14463201A IL144632A0 (en) 2001-07-30 2001-07-30 Method and pharmaceutical compositions for treating headache, nausea and migraine
PCT/IL2001/000817 WO2002019961A2 (en) 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis

Publications (1)

Publication Number Publication Date
HK1058009A1 true HK1058009A1 (en) 2004-04-30

Family

ID=26324036

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100896.1A HK1058009A1 (en) 2000-09-05 2004-02-11 Pharmaceutical compositions for headache, migraine, nausea and emesis

Country Status (22)

Country Link
US (2) US7148208B2 (es)
EP (1) EP1315505B1 (es)
JP (1) JP2004508311A (es)
KR (1) KR100849999B1 (es)
CN (1) CN100448439C (es)
AT (1) ATE375797T1 (es)
AU (2) AU2001286178B2 (es)
BR (1) BR0113698A (es)
CA (1) CA2420410C (es)
CY (1) CY1107270T1 (es)
DE (1) DE60131004T2 (es)
DK (1) DK1315505T3 (es)
ES (1) ES2296792T3 (es)
HK (1) HK1058009A1 (es)
HU (1) HUP0302362A3 (es)
IL (1) IL154456A (es)
MD (1) MD2447G2 (es)
MX (1) MXPA03001737A (es)
NO (1) NO20031902L (es)
NZ (1) NZ524903A (es)
PT (1) PT1315505E (es)
WO (1) WO2002019961A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524903A (en) * 2000-09-05 2004-11-26 Meditor Pharmaceuticals Ltd Pharmaceutical compositions comprising S-alkylisothiouronium derivatives for headache, migraine, nausea and emesis
WO2007108004A2 (en) * 2006-03-23 2007-09-27 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
EA200901591A1 (ru) * 2007-06-13 2010-06-30 Медитор Фармасьютикалс Лтд. Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом
EP2219447B1 (en) * 2007-11-06 2013-07-03 Barkan-Farma S.r.l. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (en) * 2010-08-05 2012-02-09 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
CN109523244B (zh) * 2018-11-02 2023-06-27 创新先进技术有限公司 一种基于母子账户的用于转移款项数据的方法和系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD586C2 (ro) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Substanţă medicamentoasă cu acţiune antihipotensivă "Difetur"
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
EP0928191B1 (en) * 1996-09-26 2002-08-28 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions comprising s-alkylisothiouronium derivatives
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache
MD1138C2 (ro) * 1997-02-17 1999-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Izopropilfosfit-S-izopropilizotiuroniu- substanţă cu acţiune hipertensivă
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
US6127420A (en) * 1997-08-22 2000-10-03 The Medical College Of Wisconsin Research Foundation, Inc. L-N5 -(1-imino-3-alkenyl) ornithine and related compounds and use thereof
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
US6489308B1 (en) * 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
ATE399025T1 (de) * 1999-07-21 2008-07-15 Omeros Corp Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus
NZ524903A (en) * 2000-09-05 2004-11-26 Meditor Pharmaceuticals Ltd Pharmaceutical compositions comprising S-alkylisothiouronium derivatives for headache, migraine, nausea and emesis

Also Published As

Publication number Publication date
KR20030055257A (ko) 2003-07-02
KR100849999B1 (ko) 2008-08-01
MD2447F2 (en) 2004-05-31
BR0113698A (pt) 2003-12-09
NO20031902L (no) 2003-06-09
CY1107270T1 (el) 2012-11-21
CN100448439C (zh) 2009-01-07
US20070088005A1 (en) 2007-04-19
MXPA03001737A (es) 2004-09-10
AU2001286178B2 (en) 2006-09-14
MD2447G2 (ro) 2005-12-31
HUP0302362A3 (en) 2005-05-30
ATE375797T1 (de) 2007-11-15
MD20020139A (en) 2002-11-30
ES2296792T3 (es) 2008-05-01
HUP0302362A2 (hu) 2003-11-28
WO2002019961A2 (en) 2002-03-14
US20040006044A1 (en) 2004-01-08
NZ524903A (en) 2004-11-26
WO2002019961A3 (en) 2002-08-15
EP1315505B1 (en) 2007-10-17
DE60131004D1 (de) 2007-11-29
CA2420410A1 (en) 2002-03-14
EP1315505A2 (en) 2003-06-04
CN1464788A (zh) 2003-12-31
IL154456A (en) 2013-05-30
PT1315505E (pt) 2008-01-28
DE60131004T2 (de) 2008-07-31
JP2004508311A (ja) 2004-03-18
US7148208B2 (en) 2006-12-12
US8673979B2 (en) 2014-03-18
DK1315505T3 (da) 2008-03-03
NO20031902D0 (no) 2003-04-28
EP1315505A4 (en) 2006-02-22
CA2420410C (en) 2011-04-26
AU8617801A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
AU8617801A (en) Pharmaceutical compositions for headache, migraine, nausea and emesis
ZA200701629B (en) Gyrase inhibitors and uses thereof
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
MXPA04006039A (es) Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
MX351401B (es) Metodos y composiciones para el tratamiento de infecciones persistentes y cancer por inhibicion de la ruta de muerte celular programada (pd-1).
TW200637831A (en) Triazole compounds that modulate Hsp90 activity
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
TW200738234A (en) Triazole compounds that modulate HSP90 activity
PL374191A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
TNSN05180A1 (en) Liquid pharmaceutical formulations of palonosetron
SG179083A1 (en) Pharmaceutically useful heterocycle-substituted lactams
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
NO20075099L (no) Alkynyl-pyrrolopyrmidiner og relaterte analoger som HSP90-inhibitorer
TNSN08451A1 (en) Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
TW200509924A (en) Compositions of cyclooxygenase-2 selective inhibitors and 5-HT 1B/1D agonists for the treatment and prevention of migraine
WO2006113853A3 (en) Topiramate compositions for treatment of headache
TW200740470A (en) Diclofenac formulations and methods of use
CR20230564A (es) Compuestos indol sustituidos y métodos de uso de los mismos
WO2003020280A3 (en) Compositions and use thereof in the treatment of cancer
WO2007110047A3 (de) Tergurid/ pr0tergurid zur behandlung vom chronischen schmerzen ( z. b. migräne)
MXPA05007339A (es) Derivados de alfa-aminoamida utiles como agentes antimigranosos.
AU2018268420A1 (en) Compositions comprising naphthyridine derivatives and aluminium adjuvant for use in treating solid tumors
IL133179A0 (en) Compositions and methods for inhibiting nematocyst discharge
MX2009008073A (es) Inhibidores de epoxido hidrolasa solubles para el tratamiento de sindrome metabolico y trastornos relacionados.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140830